These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37996207)

  • 1. The show and tell of cross-presentation.
    Blander JM; Yee Mon KJ; Jha A; Roycroft D
    Adv Immunol; 2023; 159():33-114. PubMed ID: 37996207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity.
    Blander JM
    Semin Immunol; 2023 Mar; 66():101713. PubMed ID: 36706521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAP-ing into the cross-presentation secrets of dendritic cells.
    Yee Mon KJ; Blander JM
    Curr Opin Immunol; 2023 Aug; 83():102327. PubMed ID: 37116384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAP dysfunction in dendritic cells enables noncanonical cross-presentation for T cell priming.
    Barbet G; Nair-Gupta P; Schotsaert M; Yeung ST; Moretti J; Seyffer F; Metreveli G; Gardner T; Choi A; Tortorella D; Tampé R; Khanna KM; García-Sastre A; Blander JM
    Nat Immunol; 2021 Apr; 22(4):497-509. PubMed ID: 33790474
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Del Balzo D; Capmany A; Cebrian I; Damiani MT
    Front Immunol; 2021; 12():662096. PubMed ID: 33936099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells.
    Montealegre S; van Endert PM
    Front Immunol; 2018; 9():3098. PubMed ID: 30666258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comings and goings of MHC class I molecules herald a new dawn in cross-presentation.
    Blander JM
    Immunol Rev; 2016 Jul; 272(1):65-79. PubMed ID: 27319343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-Like Receptor 4 Triggering Promotes Cytosolic Routing of DC-SIGN-Targeted Antigens for Presentation on MHC Class I.
    Horrevorts SK; Duinkerken S; Bloem K; Secades P; Kalay H; Musters RJ; van Vliet SJ; García-Vallejo JJ; van Kooyk Y
    Front Immunol; 2018; 9():1231. PubMed ID: 29963041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells can prime anti-tumor CD8
    MacNabb BW; Tumuluru S; Chen X; Godfrey J; Kasal DN; Yu J; Jongsma MLM; Spaapen RM; Kline DE; Kline J
    Immunity; 2022 Jun; 55(6):982-997.e8. PubMed ID: 35617964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular recycling and cross-presentation by MHC class I molecules.
    van Endert P
    Immunol Rev; 2016 Jul; 272(1):80-96. PubMed ID: 27319344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the TAP-like transporter in antigen presentation and phagosome maturation.
    Lawand M; Evnouchidou I; Baranek T; Montealegre S; Tao S; Drexler I; Saveanu L; Si-Tahar M; van Endert P
    Mol Immunol; 2019 Sep; 113():75-86. PubMed ID: 29941219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rab22a controls MHC-I intracellular trafficking and antigen cross-presentation by dendritic cells.
    Cebrian I; Croce C; Guerrero NA; Blanchard N; Mayorga LS
    EMBO Rep; 2016 Dec; 17(12):1753-1765. PubMed ID: 27861124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocytosed soluble cowpox virus protein CPXV012 inhibits antigen cross-presentation in human monocyte-derived dendritic cells.
    Spel L; Luteijn RD; Drijfhout JW; Nierkens S; Boes M; Wiertz EJH
    Immunol Cell Biol; 2018 Feb; 96(2):137-148. PubMed ID: 29363167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo.
    Ho NI; Camps MGM; de Haas EFE; Ossendorp F
    Eur J Immunol; 2018 Jul; 48(7):1164-1173. PubMed ID: 29676785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing.
    Spadaro F; Lapenta C; Donati S; Abalsamo L; Barnaba V; Belardelli F; Santini SM; Ferrantini M
    Blood; 2012 Feb; 119(6):1407-17. PubMed ID: 22184405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of MHC class I recycling and Arf6 in cross-presentation by murine dendritic cells.
    Montealegre S; Abramova A; Manceau V; de Kanter AF; van Endert P
    Life Sci Alliance; 2019 Dec; 2(6):. PubMed ID: 31740564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ongoing saga of the mechanism(s) of MHC class I-restricted cross-presentation.
    Grotzke JE; Sengupta D; Lu Q; Cresswell P
    Curr Opin Immunol; 2017 Jun; 46():89-96. PubMed ID: 28528219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins.
    Fessenden TB; Stopfer LE; Chatterjee F; Zulueta J; Mesfin J; Cordero Dumit T; Reijers I; Hoefsmit EP; Blank C; White F; Spranger S
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35820727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trogocytosis of MHC-I/peptide complexes derived from tumors and infected cells enhances dendritic cell cross-priming and promotes adaptive T cell responses.
    Zhang QJ; Li XL; Wang D; Huang XC; Mathis JM; Duan WM; Knight D; Shi R; Glass J; Zhang DQ; Eisenbach L; Jefferies WA
    PLoS One; 2008 Aug; 3(8):e3097. PubMed ID: 18769733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC cross-dressing in antigen presentation.
    MacNabb BW; Kline J
    Adv Immunol; 2023; 159():115-147. PubMed ID: 37996206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.